267 related articles for article (PubMed ID: 17007840)
1. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
[TBL] [Abstract][Full Text] [Related]
2. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
3. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
5. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.
Pacey LK; Heximer SP; Hampson DR
Mol Pharmacol; 2009 Jul; 76(1):18-24. PubMed ID: 19351745
[TBL] [Abstract][Full Text] [Related]
6. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
7. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
[TBL] [Abstract][Full Text] [Related]
8. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
10. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
[TBL] [Abstract][Full Text] [Related]
11. Audiogenic Seizures in the
Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
[TBL] [Abstract][Full Text] [Related]
12. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
[TBL] [Abstract][Full Text] [Related]
13. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
[TBL] [Abstract][Full Text] [Related]
14. Experimental models of multifactorial epilepsies: the EL mouse and mice susceptible to audiogenic seizures.
Seyfried TN; Todorova MT; Poderycki MJ
Adv Neurol; 1999; 79():279-90. PubMed ID: 10514820
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice.
De Luca G; Di Giorgio RM; Macaione S; Calpona PR; Costantino S; Di Paola ED; De Sarro A; Ciliberto G; De Sarro G
Pharmacol Biochem Behav; 2004 May; 78(1):75-81. PubMed ID: 15159136
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse model for the fragile X syndrome.
Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.
Heulens I; D'Hulst C; Van Dam D; De Deyn PP; Kooy RF
Behav Brain Res; 2012 Apr; 229(1):244-9. PubMed ID: 22285772
[TBL] [Abstract][Full Text] [Related]
18. Long-term potentiation in the hippocampus of fragile X knockout mice.
Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057
[TBL] [Abstract][Full Text] [Related]
19. Fmrp is required for the establishment of the startle response during the critical period of auditory development.
Yun SW; Platholi J; Flaherty MS; Fu W; Kottmann AH; Toth M
Brain Res; 2006 Sep; 1110(1):159-65. PubMed ID: 16887106
[TBL] [Abstract][Full Text] [Related]
20. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
